bibliographicCitation |
Dong S, Guo A, Chen Z, Wang Z, Zhang X, Huang Y, Xie Z, Yan H, Cheng H, Wu Y. RRM1 single nucleotide polymorphism -37C→A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy. Journal of Hematology & Oncology. 2010 Mar 13;3(1):10. doi: 10.1186/1756-8722-3-10. |